oc-eies
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2017 (NCT03393962)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03393962 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2017 | Guangzhou Medical University, Kunming Medical University, Shenzhen Geno-Immune Medical Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Kunming Medical University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Shenzhen Geno-Immune Medical Institute | Academic/Hospital | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1